No abstract available
MeSH terms
-
Angiogenesis Inhibitors / administration & dosage*
-
Antibodies, Monoclonal / administration & dosage
-
Antibodies, Monoclonal / economics
-
Antibodies, Monoclonal, Humanized
-
Antioxidants / therapeutic use
-
Bevacizumab
-
Combined Modality Therapy
-
Diet
-
Disease Progression
-
Genetic Therapy
-
Humans
-
Injections, Intralesional
-
Laser Coagulation
-
Macular Degeneration* / diagnosis
-
Macular Degeneration* / pathology
-
Macular Degeneration* / therapy
-
Photochemotherapy
-
Ranibizumab
-
Retina / anatomy & histology
-
Retina / pathology
-
Retina / physiopathology
-
Retinal Drusen
-
Risk Factors
-
Smoking Cessation
Substances
-
Angiogenesis Inhibitors
-
Antibodies, Monoclonal
-
Antibodies, Monoclonal, Humanized
-
Antioxidants
-
Bevacizumab
-
Ranibizumab